
SK biopharmaceuticals
Developing innovative and next-generation drugs for central nervous system.
Market cap
$6.0b
Enterprise value
$5.9b
Share price
KRW92500.00 326030.KS
Recent deals
Authorizing premium user...
Developing innovative and next-generation drugs for central nervous system.